Portfolio

RiverVest accesses forward-thinking research and clinical expertise at leading institutions across the country to found and fund biopharma and medical device companies. Entrepreneurs turn to RiverVest for the scientific, operational, financial, and investment expertise they need to achieve long-term success. 

Select to filter companies by category

Active Companies

Arch Oncology, Inc.
Avalyn Pharma, Inc.
Biolinq
Blue Jay Therapeutics
Cardialen, Inc.
Glycomine, Inc.
InterVene, Inc.
OncoResponse, Inc.
OxaluRx, Inc.
Scout Bio, Inc.
SeQure Dx
Sparrow Pharmaceuticals
VentureMed Group, Inc.
Wugen, Inc.

Exited Companies

Allakos, Inc.
Amplyx Pharmaceuticals, Inc.
Archmont Biopharma, Inc.
Cabrellis Pharmaceuticals Corporation
Cameron Health, Inc.
Centerre Healthcare Corporation
CGI Pharmaceuticals Inc.
Conforma Therapeutics Corporation
Curzion Pharmaceuticals, Inc.
CyDex Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc.
Good Therapeutics, Inc.
IDEV Technologies, Inc.
Lumena Pharmaceuticals, Inc.
Lutonix, Inc.
MacroGenics, Inc.
Mirum Pharmaceuticals, Inc.
Mpex Pharmaceuticals, Inc.
Neuros Medical, Inc.
Otonomy, Inc.
Reneo Pharmaceuticals, Inc.
Salient Surgical Technologies, Inc.
Securus Medical Group, Inc.
Spruce Biosciences, Inc.
Standard Bariatrics, Inc.
Velocimed, LLC
Xilio Therapeutics
ZS Pharma Inc.
Map
MapMapMapMapMapMap
RiverVest’s Footprint Increases Its Opportunity Set

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Learn More